In addition to Pfizer and Moderna's new formulas, Novavax's protein-based shot is an option for COVID vaccination this season ...

In addition to Pfizer and Moderna's new formulas, Novavax's protein-based shot is an option for COVID vaccination this season ...

Global biotechnology leader CSL (ASX:CSL; USOTC:CSLLY) and self-amplifying messenger RNA (sa-mRNA) pioneer Arcturus ...

Researchers found that SARS-CoV-2-specific plasma cells were largely excluded from the long-lived plasma cell compartment in ...

A head-to-head study has revealed that CSL and Arcturus Therapeutic’s self-amplifying mRNA vaccine can maintain a stronger ...

CSL Ltd. (CMXHF.PK) and Arcturus Therapeutics Holdings Inc. (ARCT), Monday announced that self-amplifying or sa-mRNA COVID-19 vaccine ...

Fairfield and UConn researchers found that lifestyle factors like BMI, birth control and stress levels affect perceived COVID-19 vaccine symptoms.

SOUTH SAN FRANCISCO, Calif., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced the initiation of the sentinel cohort of its Phase 2b clinical trial evaluating Vaxart’s ...

CAMBRIDGE, MA and TAIPEI, TAIWAN / ACCESSWIRE / September 30, 2024 / (Nasdaq:MRNA) and Cenra Healthcare, the sales and ...

CSL and Arcturus Therapeutics report that their sa-mRNA COVID-19 vaccine, ARCT-154, delivered superior immunogenicity ...

The fall virus season is upon us, and the U.S. Food & Drug Administration just approved one of the newest tools to protect ...

Alnylam Pharmaceuticals admitted defeat, for now, in a lawsuit in Delaware federal court that accused Moderna's blockbuster COVID-19 vaccines of infringing one of its patents.